These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 17611657

  • 1. Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis.
    Tsukioka M, Matsumoto Y, Noriyuki M, Yoshida C, Nobeyama H, Yoshida H, Yasui T, Sumi T, Honda K, Ishiko O.
    Oncol Rep; 2007 Aug; 18(2):361-7. PubMed ID: 17611657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K, du Bois A, Harter P, Fisseler-Eckhoff A, Kommoss F, Stauber R, Kaufmann M, Nekljudova V, Loibl S.
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [Abstract] [Full Text] [Related]

  • 4. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
    Shibata K, Kajiyama H, Mizokami Y, Ino K, Nomura S, Mizutani S, Terauchi M, Kikkawa F.
    Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Expression of glucose transporter-1 and its correlation with basic fibroblast growth factor and proliferating cell nuclear antigen in epithelial ovarian neoplasm].
    Zhao SJ, Liu JY, Ren FR, Feng YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):264-8. PubMed ID: 15924676
    [Abstract] [Full Text] [Related]

  • 7. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
    Lin CK, Chao TK, Yu CP, Yu MH, Jin JS.
    APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with topoisomerase II alpha and prognosis.
    Brustmann H.
    Gynecol Oncol; 2004 Oct; 95(1):16-22. PubMed ID: 15385105
    [Abstract] [Full Text] [Related]

  • 9. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
    Solomon LA, Munkarah AR, Schimp VL, Arabi MH, Morris RT, Nassar H, Ali-Fehmi R.
    Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F, Gumurdulu D, Erkanli S, Kayaselcuk F, Zeren H, Ali Vardar M, Kuscu E.
    Pathol Res Pract; 2008 Jun; 204(6):379-87. PubMed ID: 18343598
    [Abstract] [Full Text] [Related]

  • 12. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
    Crasta JA, Mishra S, Vallikad E.
    Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
    [Abstract] [Full Text] [Related]

  • 13. [Expression and clinical significance of endostatin and vascular endothelial growth factor in ovarian carcinoma].
    Shi HR, Song WJ, Chen ZM, Wu QH.
    Ai Zheng; 2005 Sep; 24(9):1127-31. PubMed ID: 16159439
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
    Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K.
    Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Expressions of VEGF/VEGFRs and activation of STATs in ovarian carcinoma].
    Chen BY, Ye DF, Xie X, Chen HZ, Lü WG.
    Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):33-7. PubMed ID: 15771796
    [Abstract] [Full Text] [Related]

  • 18. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival.
    Ali-Fehmi R, Morris RT, Bandyopadhyay S, Che M, Schimp V, Malone JM, Munkarah AR.
    Am J Obstet Gynecol; 2005 Mar; 192(3):819-25. PubMed ID: 15746677
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.